The American College of Physicians (ACP) released a statement supporting an “immediate ramping up of supply for distribution of COVID-19 vaccines equitably among and within countries in need.”
The prevalence of early bacterial identification is up to 3-fold lower in intubated patients with SARS-CoV-2 pneumonia compared with patients with influenza pneumonia.
The approval was based on data from a phase 3 study that evaluated Trikafta in 66 children 6 to 11 years of age with CF who were either homozygous for the F508del mutation or heterozygous for the F508del mutation and 1 minimal function mutation.
